Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.217
-0.013 (-5.79%)
At close: Dec 5, 2025, 4:00 PM EST
0.222
+0.006 (2.68%)
After-hours: Dec 5, 2025, 7:59 PM EST
Applied Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 1 | 0.46 | 9.99 | - | - | - | |
| Revenue Growth (YoY) | - | -95.45% | - | - | - | - | |
| Cost of Revenue | 39.06 | 48.74 | 53.91 | 55.63 | - | - | |
| Gross Profit | -38.06 | -48.29 | -43.91 | -55.63 | - | - | |
| Selling, General & Admin | 61.56 | 56.01 | 20.62 | 27.32 | 43.05 | 32.68 | |
| Research & Development | - | - | - | - | 62.57 | 61.79 | |
| Operating Expenses | 61.56 | 56.01 | 20.62 | 27.32 | 105.62 | 94.47 | |
| Operating Income | -99.61 | -104.3 | -64.54 | -82.95 | -105.62 | -94.47 | |
| Interest & Investment Income | 2.09 | 3.53 | 1.37 | 0.69 | 0.56 | 0.56 | |
| Other Non Operating Income (Expenses) | 78.24 | -4.78 | -56.57 | -0.07 | - | - | |
| EBT Excluding Unusual Items | -19.27 | -105.55 | -119.74 | -82.33 | -105.06 | -93.91 | |
| Gain (Loss) on Sale of Investments | -0.08 | -0.08 | -0.03 | -0.18 | -0.52 | -0.05 | |
| Pretax Income | -18.14 | -105.62 | -119.76 | -82.51 | -105.58 | -93.96 | |
| Net Income | -18.14 | -105.62 | -119.76 | -82.51 | -105.58 | -93.96 | |
| Net Income to Common | -18.14 | -105.62 | -119.76 | -82.51 | -105.58 | -93.96 | |
| Shares Outstanding (Basic) | 145 | 140 | 84 | 38 | 26 | 22 | |
| Shares Outstanding (Diluted) | 145 | 140 | 84 | 38 | 26 | 22 | |
| Shares Change (YoY) | 10.63% | 65.63% | 122.72% | 47.77% | 16.53% | 71.19% | |
| EPS (Basic) | -0.13 | -0.76 | -1.42 | -2.18 | -4.12 | -4.28 | |
| EPS (Diluted) | -0.13 | -0.76 | -1.42 | -2.18 | -4.12 | -4.28 | |
| Operating Margin | -9961.20% | -22922.86% | -645.80% | - | - | - | |
| Profit Margin | -1813.80% | -23214.07% | -1198.47% | - | - | - | |
| EBITDA | -99.61 | -104.3 | -64.53 | -82.95 | -105.62 | - | |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 | - | |
| EBIT | -99.61 | -104.3 | -64.54 | -82.95 | -105.62 | -94.47 | |
| Revenue as Reported | 1 | 0.46 | 9.99 | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.